Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013645
Filing Date
2023-08-07
Accepted
2023-08-07 17:26:25
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20230630x10q.htm   iXBRL 10-Q 1722759
2 EX-31.1 rsls-20230630xex31d1.htm EX-31.1 11729
3 EX-31.2 rsls-20230630xex31d2.htm EX-31.2 11977
4 EX-32.1 rsls-20230630xex32d1.htm EX-32.1 9397
5 EX-32.2 rsls-20230630xex32d2.htm EX-32.2 9210
  Complete submission text file 0001558370-23-013645.txt   6339032

Data Files

Seq Description Document Type Size
6 EX-101.SCH rsls-20230630.xsd EX-101.SCH 38460
7 EX-101.CAL rsls-20230630_cal.xml EX-101.CAL 52598
8 EX-101.DEF rsls-20230630_def.xml EX-101.DEF 197290
9 EX-101.LAB rsls-20230630_lab.xml EX-101.LAB 360867
10 EX-101.PRE rsls-20230630_pre.xml EX-101.PRE 297011
53 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20230630x10q_htm.xml XML 1002111
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37897 | Film No.: 231148620
SIC: 3841 Surgical & Medical Instruments & Apparatus